MedTrace Logo

Evaluation of an Adapted Formula on Atopic Dermatitis.

NCT05318300 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 126

Last updated 2023-12-08

No results posted yet for this study

Summary

The aim of this study is to show the efficiency of a new infant formula containing fiber on the management of moderate to severe atopic dermatitis.

Conditions

Interventions

DIETARY_SUPPLEMENT

tested formula with fiber

formula containing fibers

DIETARY_SUPPLEMENT

Control

formula without fiber

Sponsors & Collaborators

  • United Pharmaceuticals

    lead INDUSTRY

Principal Investigators

  • Fabienne Cahn-Sellem · Private Practice

  • Sebastien Barbarot · Hotel Dieu Hospital, Nantes, France

  • Elena Bradatan · Private Practice

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
1 Month
Max Age
18 Months
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-05-24
Primary Completion
2024-04-30
Completion
2024-04-30

Countries

  • Belgium
  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05318300 on ClinicalTrials.gov